Disparities in dolutegravir utilisation in children, adolescents and young adults (0–24 years) living with HIV. An analysis of the IeDEA Pediatric West African cohort
2025BMJ Global HealthJournalOpen access
10.1136/bmjgh-2024-016512Full text3 citations